跳至主要内容
临床试验/NCT03859843
NCT03859843Unknown3 期

Efficacy and Antimicrobial Activity of Platelet Rich Plasma (PRP) in Acne Vulgaris : A Randomized Controlled Trial

Assiut University0 个研究点目标入组 50 人开始时间: 2020年1月10日最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
50
主要终点
Cure rate

研究概览

简要总结

Efficacy and Antimicrobial activity of Platelet Rich Plasma (PRP) in Acne Vulgaris : A randomized controlled trial

详细描述

Acne vulgaris is one of the most common chronic skin diseases worldwide. The condition usually starts in adolescence, peaks at the ages of 14 to 19 years and frequently resolves by mid-twenties.

Acne is characterized by seborrhea, formation of open and closed comedones, erythematous papules and pustules and in more severe cases present with nodules, deep pustules and pseudo cysts, in many cases a degree of scarring will ensue.

Its pathophysiology includes hyperseborrhoea, abnormal follicular keratinization and Propionibacterium acnes proliferation in the pilosebaceous unit.

Acne is a significant clinical problem with sever social, psychological, and emotional implications. A mainly genetically determined host response pattern combined with bacterial ''triggering'' is generally accepted as being important for the apparently unbalanced inflammatory activity.

Acne is not an infectious disease, but three major organisms were isolated from the surface of the skin and the pilosebaceous duct of patients with acne including Propionibacterium acne, Staphylococcus epidermidis and Malassezia furfur.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with active acne vulgaris lesions (inflammatory and non-inflammatory).
  • Age range from 14 to 40 years.
  • Patients with any topical and systemic treatments will undergo wash out period of one month.

排除标准

  • Patients with herpes labials, or bacterial infection; warts on the face, actinic keratosis, or skin cancer or allergy to medications.
  • Systemic retinoids intake in the previous 6 months
  • History of keloidal scarring.
  • Patients on anticoagulant therapy or aspirin or have a coagulation issue,
  • Patients with hemoglobin less than 10g\dl or platelet less than 105 micron\l
  • Pregnant women
  • Immunocompromised patients
  • Patients with medical diseases like diabetes mellitus, epilepsy or malignancy

研究组 & 干预措施

Chemical peeling (Salycilic acid)

Active Comparator

干预措施: Chemical peeling (Salycilic acid) (Other)

Chemical peeling (Jessenr's solution)

Active Comparator

干预措施: Chemical peeling (Jessener's solution) (Other)

PRP

Active Comparator

干预措施: PRP (Combination Product)

结局指标

主要结局

Cure rate

时间窗: 3 months

Assess cure rate of PRP and Chemical peeling agents in treatment of Aactive Acne Vulgaris in 3 months duration and compare efficacy of all measures

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hiba A H alshaaby

Principal investigator

Assiut University

相似试验

Efficacy and Antimicrobial Activity of Platelet Rich... | 临床试验